OBJECTIVE: Health resource utilization (HRU) and outcomes associated with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) are not well described. Therefore, a population-based cohort study was conducted to characterize patients hospitalized with AECOPD with regard to HRU, mortality, recurrence, and predictors of readmission with AECOPD. METHODS: Using Danish healthcare databases, this study identified COPD patients with at least one AECOPD hospitalization between 2005-2009 in Northern Denmark. Hospitalized AECOPD patients' HRU, in-hospital mortality, 30-day, 60-day, 90-day, and 180-day post-discharge mortality and recurrence risk, and predictors of readmission with AECOPD in the year following study inclusion were characterized. RESULTS: This study observed 6612 AECOPD hospitalizations among 3176 prevalent COPD patients. Among all AECOPD hospitalizations, median length of stay was 6 days (interquartile range [IQR] 3-9 days); 5 days (IQR 3-9) among those without ICU stay and 11 days (IQR 7-20) among the 8.6% admitted to the ICU. Mechanical ventilation was provided to 193 (2.9%) and non-invasive ventilation to 479 (7.2%) admitted patients. In-hospital mortality was 5.6%. Post-discharge mortality was 4.2%, 7.8%, 10.5%, and 17.4% at 30, 60, 90, and 180 days, respectively. Mortality and readmission risk increased with each AECOPD hospitalization experienced in the first year of follow-up. Readmission at least twice in the first year of follow-up was observed among 286 (9.0%) COPD patients and was related to increasing age, male gender, obesity, asthma, osteoporosis, depression, myocardial infarction, diabetes I and II, any malignancy, and hospitalization with AECOPD or COPD in the prior year. LIMITATIONS: The study included only hospitalized AECOPD patients among prevalent COPD patients. Furthermore, information was lacking on clinical variables. CONCLUSION: These findings indicate that AECOPD hospitalizations are associated with substantial mortality and risk of recurrence.
OBJECTIVE: Health resource utilization (HRU) and outcomes associated with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) are not well described. Therefore, a population-based cohort study was conducted to characterize patients hospitalized with AECOPD with regard to HRU, mortality, recurrence, and predictors of readmission with AECOPD. METHODS: Using Danish healthcare databases, this study identified COPDpatients with at least one AECOPD hospitalization between 2005-2009 in Northern Denmark. Hospitalized AECOPDpatients' HRU, in-hospital mortality, 30-day, 60-day, 90-day, and 180-day post-discharge mortality and recurrence risk, and predictors of readmission with AECOPD in the year following study inclusion were characterized. RESULTS: This study observed 6612 AECOPD hospitalizations among 3176 prevalent COPDpatients. Among all AECOPD hospitalizations, median length of stay was 6 days (interquartile range [IQR] 3-9 days); 5 days (IQR 3-9) among those without ICU stay and 11 days (IQR 7-20) among the 8.6% admitted to the ICU. Mechanical ventilation was provided to 193 (2.9%) and non-invasive ventilation to 479 (7.2%) admitted patients. In-hospital mortality was 5.6%. Post-discharge mortality was 4.2%, 7.8%, 10.5%, and 17.4% at 30, 60, 90, and 180 days, respectively. Mortality and readmission risk increased with each AECOPD hospitalization experienced in the first year of follow-up. Readmission at least twice in the first year of follow-up was observed among 286 (9.0%) COPDpatients and was related to increasing age, male gender, obesity, asthma, osteoporosis, depression, myocardial infarction, diabetes I and II, any malignancy, and hospitalization with AECOPD or COPD in the prior year. LIMITATIONS: The study included only hospitalized AECOPDpatients among prevalent COPDpatients. Furthermore, information was lacking on clinical variables. CONCLUSION: These findings indicate that AECOPD hospitalizations are associated with substantial mortality and risk of recurrence.
Authors: Gary T Ferguson; Bonnie Beck; Emmanuelle Clerisme-Beaty; Dacheng Liu; Byron M Thomashow; Robert A Wise; Richard ZuWallack; Barry J Make Journal: Chronic Obstr Pulm Dis Date: 2017-08-10
Authors: Sigrun Alba Johannesdottir Schmidt; Martin Berg Johansen; Morten Olsen; Xiao Xu; Joseph M Parker; Nestor A Molfino; Timothy L Lash; Henrik Toft Sørensen; Christian Fynbo Christiansen Journal: BMJ Open Date: 2014-12-19 Impact factor: 2.692
Authors: Katrine P Lindvig; Anne C Brøchner; Annmarie T Lassen; Søren Mikkelsen Journal: Scand J Trauma Resusc Emerg Med Date: 2017-11-02 Impact factor: 2.953
Authors: Katy C Norman; Christine M Freeman; Neha S Bidthanapally; MeiLan K Han; Fernando J Martinez; Jeffrey L Curtis; Kelly B Arnold Journal: Cell Mol Bioeng Date: 2019-03-15 Impact factor: 2.321
Authors: C Echevarria; J Steer; K Heslop-Marshall; S C Stenton; P M Hickey; R Hughes; M Wijesinghe; R N Harrison; N Steen; A J Simpson; G J Gibson; S C Bourke Journal: Thorax Date: 2016-02 Impact factor: 9.139